General Information of This Metabolic Reaction (MR) (ID:
MR001655) |
Formula |
|
Reactant |
N-Desmethylaminopyrine |
Product |
4-amino-antipyrine (AA) |
Reactant Info
|
Product Info
|
Metabolic Enzyme
|
Cytochrome P450 2B6 (CYP2B6)
|
DME Info
|
Cytochrome P450 2C8 (CYP2C8)
|
DME Info
|
Cytochrome P450 3A4 (CYP3A4)
|
DME Info
|
Cytochrome P450 2C9 (CYP2C9)
|
DME Info
|
Metabolic Type
|
Oxidation
-
N-Demethylation
|
|
|
|
|
|
|
|
Other MR(s) Related to The Reactant of This MR |
Other MR(s) That Produce The Reactant of This MR
|
|
Other MR(s) That Metabolize The Reactant of This MR
|
|
Other MR(s) Related to The Product of This MR |
Other MR(s) That Produce The Product of This MR
|
|
Other MR(s) That Metabolize The Produtc of This MR
|
|
References |
1 |
Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675.
|
2 |
Metamizole (Dipyrone) and the Liver: A Review of the Literature J Clin Pharmacol. 2019 Nov;59(11):1433-1442. doi: 10.1002/jcph.1512.
|
3 |
Clinical pharmacokinetics of dipyrone and its metabolites Clin Pharmacokinet. 1995 Mar;28(3):216-34. doi: 10.2165/00003088-199528030-00004.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.